<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "journalpublishing.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="2.0" xml:lang="en" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">JMIR Perioper Med</journal-id><journal-id journal-id-type="publisher-id">periop</journal-id><journal-id journal-id-type="index">32</journal-id><journal-title>JMIR Perioperative Medicine</journal-title><abbrev-journal-title>JMIR Perioper Med</abbrev-journal-title><issn pub-type="epub">2561-9128</issn><publisher><publisher-name>JMIR Publications</publisher-name><publisher-loc>Toronto, Canada</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">v9i1e99623</article-id><article-id pub-id-type="doi">10.2196/99623</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Preoperative Mortality Risk Prediction and Equity Using Preoperative Score to Predict Postoperative Mortality in a Diverse US Surgical Population: Retrospective Cohort Study</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Hall</surname><given-names>Jackson</given-names></name><degrees>BS</degrees><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="equal-contrib1">*</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Warzecha</surname><given-names>Haley</given-names></name><degrees>BA</degrees><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="equal-contrib1">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Penhallurick</surname><given-names>Chase</given-names></name><degrees>BA</degrees><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bellala</surname><given-names>Venkatsai</given-names></name><degrees>BS</degrees><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Asher</surname><given-names>Shyamal</given-names></name><degrees>MD, MBA</degrees><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1"><institution>Department of Anesthesiology, Brown University Health, Brown University</institution><addr-line>593 Eddy Street, Davol 129</addr-line><addr-line>Providence</addr-line><addr-line>RI</addr-line><country>United States</country></aff><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Steenstra</surname><given-names>Ivan</given-names></name></contrib><contrib contrib-type="editor"><name name-style="western"><surname>Cummings</surname><given-names>Kenneth</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name name-style="western"><surname>Riddle</surname><given-names>Daniel</given-names></name></contrib><contrib contrib-type="reviewer"><name name-style="western"><surname>Hollis</surname><given-names>Kate Fultz</given-names></name></contrib></contrib-group><author-notes><corresp>Correspondence to Shyamal Asher, MD, MBA, Department of Anesthesiology, Brown University Health, Brown University, 593 Eddy Street, Davol 129, Providence, RI, 02903, United States, 1 401-444-5172; <email>Shyamal_asher@brown.edu</email></corresp><fn fn-type="equal" id="equal-contrib1"><label>*</label><p>these authors contributed equally</p></fn></author-notes><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>18</day><month>11</month><year>2026</year></pub-date><volume>9</volume><elocation-id>e99623</elocation-id><history><date date-type="received"><day>28</day><month>04</month><year>2026</year></date><date date-type="rev-recd"><day>27</day><month>10</month><year>2026</year></date><date date-type="accepted"><day>27</day><month>10</month><year>2026</year></date></history><copyright-statement>&#x00A9; Jackson Hall, Haley Warzecha, Chase Penhallurick, Venkatsai Bellala, Shyamal Asher. Originally published in JMIR Perioperative Medicine (<ext-link ext-link-type="uri" xlink:href="http://periop.jmir.org">http://periop.jmir.org</ext-link>), 18.11.2026. </copyright-statement><copyright-year>2026</copyright-year><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Perioperative Medicine, is properly cited. The complete bibliographic information, a link to the original publication on <ext-link ext-link-type="uri" xlink:href="http://periop.jmir.org">http://periop.jmir.org</ext-link>, as well as this copyright and license information must be included.</p></license><self-uri xlink:type="simple" xlink:href="https://periop.jmir.org/2026/1/e99623"/><abstract><sec><title>Background</title><p>The Preoperative Score to Predict Postoperative Mortality (POSPOM), a point-based score using only preoperative variables, was developed and validated to predict in-hospital postoperative mortality in European surgical cohorts. Other widely used clinical risk tools perform differently across racial and socioeconomic groups. Although postoperative mortality has been studied in diverse US surgical populations, POSPOM performance across racial and ethnic subgroups remains insufficiently characterized.</p></sec><sec><title>Objective</title><p>This study aimed to evaluate POSPOM performance for 30-day postoperative mortality in a diverse US cohort and explore its performance for 1-year mortality among high-risk surgical patients and across racial and ethnic subgroups.</p></sec><sec sec-type="methods"><title>Methods</title><p>We performed a retrospective cohort study using the All of Us Research Program. Adults aged 18 to 91 years who underwent 1 of 21 POSPOM-eligible surgical procedures were included, and only each participant&#x2019;s most recent eligible procedure was analyzed. POSPOM scores were calculated from age, procedure type, and 15 weighted comorbidities. The primary outcome was 30-day postoperative mortality, as incomplete discharge data precluded reliable assessment of in-hospital mortality; 1-year mortality was examined as an exploratory secondary outcome. Logistic regression estimated odds ratios (ORs) per 1-point increase in the POSPOM score, and discrimination was evaluated using the area under the receiver operating characteristic curve (AUC). A high-risk subgroup (procedure points &#x2265;14) was analyzed separately, and outcomes across racial and ethnic subgroups were explored descriptively. Given the small subgroup sizes and few events, subgroup analyses were interpreted cautiously.</p></sec><sec sec-type="results"><title>Results</title><p>Among 17,262 patients, 12 (0.1%) died within 30 days and 45 (0.3%) within 1 year. For 30-day mortality, POSPOM yielded an AUC of 0.764, with higher odds of death per point (OR 1.112, 95% CI 1.040-1.190; <italic>P</italic>=.002). Discrimination was lower for 1-year mortality (AUC 0.638; OR 1.054, 95% CI 1.017-1.092; <italic>P</italic>=.004). In the high-risk subgroup (n=536; 30-day mortality 1.1%, 1-year mortality 2.1%), the 30-day AUC fell to 0.583, with no significant association (OR 0.942, 95% CI 0.812-1.092; <italic>P</italic>=.43). For 1-year mortality, the AUC was 0.692, with an inverse association (OR 0.882, 95% CI 0.781-0.998; <italic>P</italic>=.046). Descriptively, high-risk Black patients had higher 30-day mortality than White patients (2/61, 3.3% vs 4/348, 1.1%); no deaths were recorded among Asian, other-race, or Hispanic high-risk patients.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>POSPOM demonstrated an AUC of 0.764 for 30-day mortality overall but provided limited risk stratification among high-risk surgical patients. Higher observed mortality among high-risk Black patients suggests the score may not fully capture baseline risk across racial groups, possibly reflecting structural and social factors outside its scope. As the 1-year and subgroup analyses were exploratory with few events, larger, adequately powered US studies are needed to evaluate POSPOM at its intended in-hospital end point, assess calibration across diverse populations, and inform recalibration before broader clinical use.</p></sec></abstract><kwd-group><kwd>preoperative care</kwd><kwd>postoperative mortality</kwd><kwd>risk assessment</kwd><kwd>health care disparities</kwd><kwd>socioeconomic factors</kwd><kwd>comorbidity</kwd></kwd-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The Preoperative Score to Predict Postoperative Mortality (POSPOM) is a validated, point-based tool that estimates postoperative mortality using only preoperative variables, including age, comorbidities, and surgical procedure type [<xref ref-type="bibr" rid="ref1">1</xref>]. Developed to support early risk stratification, POSPOM intentionally excludes subjective clinician judgment and intraoperative data, making it relatively simple to implement across different hospitals and practice settings [<xref ref-type="bibr" rid="ref1">1</xref>]. POSPOM was originally developed and validated to predict in-hospital postoperative mortality, with &#x201C;good calibration and excellent discrimination&#x201D; reported in large European surgical cohorts [<xref ref-type="bibr" rid="ref1">1</xref>].</p><p>Postoperative mortality has previously been examined in large, demographically diverse US surgical cohorts. Smith et al [<xref ref-type="bibr" rid="ref2">2</xref>] evaluated postoperative mortality risk estimates and 1-year survival among Veterans Health Administration surgical patients, while Kaiser et al [<xref ref-type="bibr" rid="ref3">3</xref>] examined 30-day mortality in a large multicenter cohort of noncardiac surgical patients. However, these studies did not specifically evaluate POSPOM performance across racial and ethnic subgroups. Prior studies have shown that widely used clinical prediction tools, including the Sequential Organ Failure Assessment (SOFA) score, the American College of Surgeons National Surgical Quality Improvement Program surgical risk calculator, and cardiovascular risk equations, can exhibit differential performance across racial and socioeconomic groups [<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref4">4</xref>-<xref ref-type="bibr" rid="ref8">8</xref>]. These findings have raised concerns that risk models may not perform equally across different patient populations, treatment decisions, and outcomes [<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref4">4</xref>-<xref ref-type="bibr" rid="ref8">8</xref>].</p><p>Although prior studies have examined postoperative mortality prediction in diverse US surgical populations, POSPOM performance across racial and ethnic subgroups has not been specifically characterized [<xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref3">3</xref>]. Evaluating POSPOM across these subgroups may help determine whether its predictive performance remains consistent across heterogeneous surgical populations.</p><p>Hospital discharge dates were not available for all participants in the All of Us dataset, preventing reliable assessment of in-hospital mortality across the full cohort [<xref ref-type="bibr" rid="ref9">9</xref>]. We therefore selected 30-day mortality as the primary outcome because it provided a standardized postoperative interval that could be applied consistently across participants. We additionally examined 1-year mortality as an exploratory secondary outcome to assess the longer-term association between preoperative POSPOM scores and postoperative mortality.</p><p>The primary objective of this study was to evaluate POSPOM performance for 30-day postoperative mortality in a large, demographically diverse US cohort from the All of Us Research Program [<xref ref-type="bibr" rid="ref9">9</xref>]. Secondary exploratory objectives were to evaluate performance for 1-year mortality, performance among high-risk surgical patients, and performance across racial and ethnic subgroups. We hypothesized that, similar to other clinical risk prediction tools, POSPOM may not perform consistently across demographic subgroups, particularly among patients undergoing high-risk surgical procedures [<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref4">4</xref>-<xref ref-type="bibr" rid="ref6">6</xref>].</p></sec><sec id="s2" sec-type="methods"><title>Methods</title><sec id="s2-1"><title>Study Design and Data Source</title><p>This retrospective cohort study evaluated POSPOM performance for 30-day postoperative mortality in a large-scale, diverse, real-world US population, with secondary exploratory analyses of 1-year mortality and demographic subgroups. Data were derived from the National Institutes of Health (NIH) All of Us Research Program&#x2019;s Registered Tier Dataset version 8, which includes electronic health record (EHR) data from more than 1 million participants [<xref ref-type="bibr" rid="ref9">9</xref>]. Clinical information was extracted from the Observational Medical Outcomes Partnership (OMOP) Common Data Model version 5.3.1, using tables for demographics, procedures, condition occurrences, surveys, and death records [<xref ref-type="bibr" rid="ref10">10</xref>]. This retrospective study was not prospectively registered, and no formal study protocol was published.</p></sec><sec id="s2-2"><title>Study Population</title><p>The initial cohort was identified from participants with recorded condition and procedure domains. To ensure independent observations among participants with multiple eligible surgeries, only the most recent procedure was included for the analysis. Participants were included in the final analytic cohort if they were aged 18 to 91 years at the time of data collection and underwent 1 of the 21 POSPOM-eligible surgical procedures.</p><p>Participants were excluded from the analysis if they fell outside the specified age range, had missing demographic or surgical data required for cohort eligibility or POSPOM score calculation, or underwent surgical procedures not covered by the POSPOM classification system.</p><p>Following these criteria, the final analytic cohort consisted of 17,262 patients.</p></sec><sec id="s2-3"><title>Data Extraction and Processing</title><p>Demographic variables, including sex at birth, race, and ethnicity, were cleaned and standardized for analysis. Race was categorized as White, Black, Asian, or other, and ethnicity was coded as a binary variable (Hispanic vs non-Hispanic). Sex at birth was recoded as male or female.</p></sec><sec id="s2-4"><title>POSPOM Score Calculation</title><p>Each participant&#x2019;s total POSPOM score was computed as the sum of 3 components&#x2014;age, procedure type, and comorbidities&#x2014;with total possible scores ranging from 0 to 54 points. The complete scoring criteria, including all variables and point allocations, are detailed in <xref ref-type="table" rid="table1">Table 1</xref>.</p><table-wrap id="t1" position="float"><label>Table 1.</label><caption><p>Components and point allocations for the Preoperative Score to Predict Postoperative Mortality (POSPOM)<sup><xref ref-type="table-fn" rid="table1fn1">a</xref></sup>.</p></caption><table id="table1" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom" colspan="2">Category and characteristic</td><td align="left" valign="bottom">POSPOM points</td></tr></thead><tbody><tr><td align="left" valign="top" colspan="3">Patient age (y)</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>&#x003C;45</td><td align="left" valign="top">0</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>45-49</td><td align="left" valign="top">1</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>50-54</td><td align="left" valign="top">2</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>55-59</td><td align="left" valign="top">3</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>60-64</td><td align="left" valign="top">4</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>65-69</td><td align="left" valign="top">5</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>70-74</td><td align="left" valign="top">6</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>75-79</td><td align="left" valign="top">7</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>80-84</td><td align="left" valign="top">8</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>85-89</td><td align="left" valign="top">9</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>&#x2265;90</td><td align="left" valign="top">10</td></tr><tr><td align="left" valign="top" colspan="3">Comorbidities</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Ischemic heart disease</td><td align="left" valign="top">1</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Cardiac arrhythmia or heart blocks</td><td align="left" valign="top">1</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Chronic heart failure or cardiomyopathy</td><td align="left" valign="top">4</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Peripheral vascular disease</td><td align="left" valign="top">1</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Dementia</td><td align="left" valign="top">2</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Cerebrovascular disease</td><td align="left" valign="top">1</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Hemiplegia</td><td align="left" valign="top">4</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Chronic obstructive pulmonary disease</td><td align="left" valign="top">1</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Chronic respiratory failure</td><td align="left" valign="top">3</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Chronic alcohol abuse</td><td align="left" valign="top">4</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Cancer</td><td align="left" valign="top">4</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Diabetes</td><td align="left" valign="top">1</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Transplanted organs</td><td align="left" valign="top">2</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Preoperative chronic dialysis</td><td align="left" valign="top">1</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Chronic renal failure</td><td align="left" valign="top">2</td></tr><tr><td align="left" valign="top" colspan="3">Surgical category</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Endoscopic digestive</td><td align="left" valign="top">0</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Ophthalmologic</td><td align="left" valign="top">0</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Gynecologic</td><td align="left" valign="top">6</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Other orthopedic</td><td align="left" valign="top">6</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Interventional cardiorhythmology</td><td align="left" valign="top">8</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Arthroplasty and spine</td><td align="left" valign="top">9</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Ear, nose, and throat</td><td align="left" valign="top">9</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Minor urologic</td><td align="left" valign="top">9</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Plastic</td><td align="left" valign="top">9</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Major urologic</td><td align="left" valign="top">12</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Other surgery</td><td align="left" valign="top">12</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Minor hepatic</td><td align="left" valign="top">12</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Minor gastrointestinal</td><td align="left" valign="top">13</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Renal transplant</td><td align="left" valign="top">13</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Minor vascular</td><td align="left" valign="top">13</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Orthopedic trauma</td><td align="left" valign="top">14</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Major hepatic</td><td align="left" valign="top">15</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Thoracic</td><td align="left" valign="top">15</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Neurosurgery</td><td align="left" valign="top">15</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Major vascular</td><td align="left" valign="top">16</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Major gastrointestinal</td><td align="left" valign="top">16</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Interventional neuroradiology</td><td align="left" valign="top">17</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Cardiac</td><td align="left" valign="top">17</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Transplant</td><td align="left" valign="top">22</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Multiple trauma related</td><td align="left" valign="top">22</td></tr></tbody></table><table-wrap-foot><fn id="table1fn1"><p><sup>a</sup>Adapted from Le Manach et al [<xref ref-type="bibr" rid="ref1">1</xref>].</p></fn></table-wrap-foot></table-wrap><p>Points were assigned based on 5-year age brackets at the time of surgery, ranging from 0 points for patients younger than 45 years to 10 points for patients aged 90 years or older, as detailed in <xref ref-type="table" rid="table1">Table 1</xref>.</p><p>Procedures were mapped to POSPOM categories using Current Procedural Terminology and Systematized Nomenclature of Medicine Clinical Terms codes. Points associated with these procedures ranged from 0 for low-risk procedures (eg, colonoscopy and cataract surgery) to 22 for high-risk procedures (eg, liver transplantation).</p><p>Fifteen distinct comorbidities were identified using OMOP concept identifiers and mapped to diagnostic codes. To ensure comprehensive capture, structured query language queries used OMOP concept identifiers to include all descendant codes. Weights were applied to each condition, ranging from 1 point for conditions such as diabetes or chronic obstructive pulmonary disease to 4 points for chronic heart failure or malignant neoplastic disease.</p></sec><sec id="s2-5"><title>Outcome Measures</title><p>The primary outcome was 30-day postoperative mortality, defined as death occurring within 30 days of the index surgical procedure. POSPOM was originally developed to predict in-hospital mortality; however, hospital discharge dates were not available for all participants, preventing reliable assessment of this outcome across the full cohort [<xref ref-type="bibr" rid="ref1">1</xref>]. Thirty-day mortality was therefore selected as a standardized postoperative outcome that could be consistently assessed across participants. The secondary outcome was 1-year postoperative mortality, defined as death occurring within 365 days of the index surgical procedure. Mortality status and dates were derived from the OMOP death domain, and time from surgery to death was calculated. Participants without a recorded death date in the EHR were assumed to have survived through the relevant follow-up interval.</p></sec><sec id="s2-6"><title>Statistical Analysis</title><p>A logistic regression model was used for the primary analysis, with the continuous POSPOM score as the predictor and 30-day mortality as the binary outcome. Model performance was evaluated through discrimination and calibration. Discrimination was measured by the concordance statistic (C-statistic or area under the receiver operating characteristic curve [AUC]). In accordance with recent consensus, qualitative labels for model discrimination were avoided, and continuous AUC values were reported directly [<xref ref-type="bibr" rid="ref11">11</xref>]. Calibration was assessed using the Hosmer-Lemeshow goodness-of-fit test and calibration plots comparing observed vs predicted mortality rates. Effect estimation used logistic regression to calculate odds ratios (ORs) for mortality per 1-point increase in the POSPOM score, reported with 95% CIs.</p><p>To evaluate model fairness and calibration across different demographic strata, a stratified analysis was conducted specifically for high-risk procedures, defined as a POSPOM procedure score of 14 or greater [<xref ref-type="bibr" rid="ref1">1</xref>]. Exploratory subgroup analyses were conducted by race and ethnicity.</p></sec><sec id="s2-7"><title>Data Quality and Validation</title><p>Data quality checks included assessment of missingness for key variables, validation of date ranges (restricting surgery dates to 1980-2023), verification of age calculations (&#x2265;18 years), and evaluation of mortality data completeness. The low number of mortality events limited statistical precision, particularly in subgroup analyses; these findings were therefore interpreted cautiously.</p></sec><sec id="s2-8"><title>Software and Tools</title><p>Data extraction and processing were performed using Python (version 3.10; Python Software Foundation) with the pandas and NumPy libraries. Statistical analyses were conducted using <italic>statsmodels</italic> and scikit-learn, while visualizations were generated with Matplotlib and Seaborn. All queries and data management were conducted through the BigQuery environment within the All of Us researcher workbench.</p></sec><sec id="s2-9"><title>Ethical Considerations</title><p>All data were deidentified in accordance with All of Us privacy protocols. No direct participant contact or intervention occurred. Analyses were performed under an approved data use agreement, and all findings are presented in aggregate form to protect participant confidentiality. The Brown University Institutional Review Board (IRB) formally reviewed this study and determined that it did not constitute human subjects research under federal regulations because it exclusively used deidentified registered tier data from the NIH All of Us Research Program. The overarching All of Us data collection protocol is independently reviewed and approved by the program&#x2019;s central IRB. Patients and members of the public were not directly involved in the design, conduct, analysis, or reporting of this study.</p></sec></sec><sec id="s3" sec-type="results"><title>Results</title><sec id="s3-1"><title>Cohort Characteristics and Overall Mortality</title><p>The study analyzed an analytic cohort of 17,262 participants who underwent POSPOM-eligible surgical procedures. Within this overall population, the absolute mortality event rate was low: 12 (0.1%) participants died within 30 days of their index surgery and 45 (0.3%) participants died within 1 year. A subset of 536 (3.1%) participants were categorized as high-risk based on a POSPOM surgical procedure score of 14 or greater. Mortality rates were notably higher in this high-risk subset, with 6 (1.1%) deaths occurring at 30 days and 11 (2.1%) deaths occurring at 1 year. The detailed predictive performance of the POSPOM score across these groups is summarized in <xref ref-type="table" rid="table2">Table 2</xref>.</p><table-wrap id="t2" position="float"><label>Table 2.</label><caption><p>Predictive performance of the Preoperative Score to Predict Postoperative Mortality (POSPOM) score across the overall cohort and high-risk subgroups.</p></caption><table id="table2" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Group</td><td align="left" valign="bottom">Outcome type</td><td align="left" valign="bottom">Participants, n</td><td align="left" valign="bottom">Deaths, n (%)</td><td align="left" valign="bottom">AUC<sup><xref ref-type="table-fn" rid="table2fn1">a</xref></sup></td><td align="left" valign="bottom">OR<sup><xref ref-type="table-fn" rid="table2fn2">b</xref></sup> (95% CI)</td><td align="left" valign="bottom"><italic>P</italic> value</td></tr></thead><tbody><tr><td align="left" valign="top">All patients</td><td align="left" valign="top">30-d</td><td align="left" valign="top">17,262</td><td align="left" valign="top">12 (0.1)</td><td align="left" valign="top">0.764</td><td align="left" valign="top">1.112 (1.040-1.190)</td><td align="left" valign="top">.002</td></tr><tr><td align="left" valign="top">All patients</td><td align="left" valign="top">1-y</td><td align="left" valign="top">17,262</td><td align="left" valign="top">45 (0.3)</td><td align="left" valign="top">0.638</td><td align="left" valign="top">1.054 (1.017-1.092)</td><td align="left" valign="top">.004</td></tr><tr><td align="left" valign="top">High-risk (POSPOM score &#x2265;14)</td><td align="left" valign="top">30-d</td><td align="left" valign="top">536</td><td align="left" valign="top">6 (1.1)</td><td align="left" valign="top">0.583</td><td align="left" valign="top">0.942 (0.812-1.092)</td><td align="left" valign="top">.43</td></tr><tr><td align="left" valign="top">High-risk (POSPOM score &#x2265;14)</td><td align="left" valign="top">1-y</td><td align="left" valign="top">536</td><td align="left" valign="top">11 (2.1)</td><td align="left" valign="top">0.692</td><td align="left" valign="top">0.882 (0.781-0.998)</td><td align="left" valign="top">.046</td></tr><tr><td align="left" valign="top">Asian (High-risk)</td><td align="left" valign="top">30-d</td><td align="left" valign="top">9</td><td align="left" valign="top">0 (0)</td><td align="left" valign="top">&#x2014;<sup><xref ref-type="table-fn" rid="table2fn3">c</xref></sup></td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top">Black (High-risk)</td><td align="left" valign="top">30-d</td><td align="left" valign="top">61</td><td align="left" valign="top">2 (3.3)</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top">Other (High-risk)</td><td align="left" valign="top">30-d</td><td align="left" valign="top">118</td><td align="left" valign="top">0 (0)</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td></tr><tr><td align="left" valign="top">White (High-risk)</td><td align="left" valign="top">30-d</td><td align="left" valign="top">348</td><td align="left" valign="top">4 (1.2)</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">&#x2014;</td></tr></tbody></table><table-wrap-foot><fn id="table2fn1"><p><sup>a</sup>AUC: area under the receiver operating characteristic curve.</p></fn><fn id="table2fn2"><p><sup>b</sup>OR: odds ratio.</p></fn><fn id="table2fn3"><p><sup>c</sup>Not applicable.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3-2"><title>Overall POSPOM Score Performance</title><p>In the primary analysis of the overall cohort, the POSPOM model demonstrated an AUC of 0.764 for 30-day mortality (<xref ref-type="fig" rid="figure1">Figure 1</xref>). Logistic regression indicated that each 1-point increase in the POSPOM score was associated with a statistically significant increase in the odds of 30-day mortality (OR 1.112, 95% CI 1.040-1.190; <italic>P</italic>=.002). When evaluating longer-term outcomes, the model&#x2019;s discriminative ability decreased; for 1-year mortality, the model produced an AUC of 0.638 (<xref ref-type="fig" rid="figure1">Figure 1</xref>), and each 1-point score increase was associated with a smaller increase in mortality odds (OR 1.054, 95% CI 1.017-1.092; <italic>P</italic>=.004).</p><fig position="float" id="figure1"><label>Figure 1.</label><caption><p>Receiver operating characteristic curves showing Preoperative Score to Predict Postoperative Mortality score performance for 30-day vs 1-year mortality in the overall cohort. AUC: area under the receiver operating characteristic curve.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="periop_v9i1e99623_fig01.png"/></fig></sec><sec id="s3-3"><title>Performance in High-Risk and Demographic Subgroups</title><p>When the analysis was restricted to the high-risk surgical cohort (n=536), model discrimination dropped considerably. For 30-day mortality in this subgroup, the POSPOM score yielded an AUC of 0.583 (<xref ref-type="fig" rid="figure2">Figure 2</xref>), with the score no longer showing a positive association with mortality (OR 0.942, 95% CI 0.812-1.092; <italic>P</italic>=.43). For 1-year mortality in the high-risk cohort, the AUC was 0.692 (<xref ref-type="fig" rid="figure2">Figure 2</xref>), and a 1-point increase in the POSPOM score was inversely associated with mortality odds (OR 0.882, 95% CI 0.781-0.998; <italic>P</italic>=.046).</p><fig position="float" id="figure2"><label>Figure 2.</label><caption><p>Receiver operating characteristic curves showing Preoperative Score to Predict Postoperative Mortality score performance for 30-day vs 1-year mortality in the high-risk surgical cohort. AUC: area under the receiver operating characteristic curve.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="periop_v9i1e99623_fig02.png"/></fig><p>Race-stratified analyses within the high-risk cohort were evaluated descriptively due to small sample sizes. Among Black patients (n=61), there were 2 (3.3%) recorded 30-day deaths. Among White patients (n=348), there were 4 (1.2%) recorded 30-day deaths. No mortality events were recorded among Asian (n=9) or other (n=118) racial groups within the high-risk cohort. In ethnicity-stratified analyses, the Hispanic subgroup (n=72) recorded no mortality events, while the non-Hispanic group (n=464) recorded 11 deaths at 1 year.</p></sec></sec><sec id="s4" sec-type="discussion"><title>Discussion</title><sec id="s4-1"><title>Principal Findings</title><p>This retrospective cohort study evaluated POSPOM performance in a diverse US surgical population, with an exploratory assessment of outcomes across racial and ethnic subgroups. For 30-day mortality in the overall surgical cohort, POSPOM demonstrated an AUC of 0.764, but its performance decreased among high-risk patients (AUC 0.583) and for the 1-year outcome (AUC 0.638). In exploratory subgroup analyses, discrimination appeared to be higher among Black participants; however, event counts were small and should be interpreted cautiously. Although a higher absolute mortality rate was observed among Black patients compared with White patients within this high-risk subset, our data are insufficient to conclude whether the model differentially accounts for underlying baseline risk. These findings underscore the need for larger, adequately powered US validation studies to assess model calibration across minoritized populations.</p></sec><sec id="s4-2"><title>General Performance and High-Risk Limitations</title><p>The initial validation of POSPOM in large European cohorts suggested that it was a robust and objective alternative to more subjective risk assessments [<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref4">4</xref>]. The AUC of 0.764 observed for 30-day mortality supports the potential utility of POSPOM for standardized short-term postoperative risk assessment in diverse US populations. However, the decline in discrimination among high-risk surgical patients (AUC 0.583 for 30-day mortality in those with surgical points &#x2265;14) indicates limited predictive performance in this subgroup. In these patients, the score did not provide meaningful risk stratification. For the 1-year outcome, an inverse association was observed within the high-risk subgroup. Given the small number of events and the fact that POSPOM was not developed for long-term mortality prediction, this finding should be interpreted cautiously and warrants evaluation in a larger cohort.</p><p>The outcomes evaluated in this study differ from the in-hospital mortality end point for which POSPOM was originally developed [<xref ref-type="bibr" rid="ref1">1</xref>]. Because hospital discharge dates were unavailable for some participants, in-hospital mortality could not be reliably assessed across the full cohort. We therefore used 30-day mortality as a standardized primary outcome and examined 1-year mortality as an exploratory secondary outcome. Future studies with complete admission and discharge data should evaluate POSPOM performance at its intended in-hospital end point in diverse US populations.</p><p>Given the low number of events, all of the estimates, especially those from subgroup analyses, are subject to statistical uncertainty.</p></sec><sec id="s4-3"><title>Equity and Racial Disparities</title><p>A central objective of this study was to assess whether POSPOM exhibits performance disparities across demographic lines, similar to other clinical tools [<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref8">8</xref>]. Due to small sample sizes in the high-risk subgroup, outcomes across racial groups were evaluated descriptively. Notably, despite similar preoperative risk categorization, Black patients had a 30-day mortality rate 3 times higher than that of White patients (2/61, 3.3% vs 4/348, 1.2%) and a 1-year mortality rate more than triple that of their White counterparts (6.6% vs 2%).</p><p>These descriptive findings suggest that the point-based POSPOM system may underrepresent the absolute risk faced by Black patients. This disparity likely reflects broader structural inequities in health care access, the impact of social determinants of health, or differences in hospital quality that the POSPOM score is not designed to capture [<xref ref-type="bibr" rid="ref1">1</xref>]. Although we did not analyze insurance status, hospital volume, or nonsurgical participants, prior literature indicates these systemic factors may heavily influence US surgical outcomes [<xref ref-type="bibr" rid="ref12">12</xref>-<xref ref-type="bibr" rid="ref14">14</xref>]. As a purely clinical tool, POSPOM does not account for these external health care system variances [<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref4">4</xref>].</p></sec><sec id="s4-4"><title>Comparison With Existing Risk Models</title><p>The performance variations and racial mortality gaps observed in this study align with emerging literature regarding algorithmic bias in clinical risk calculators [<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref14">14</xref>-<xref ref-type="bibr" rid="ref17">17</xref>]. For instance, studies evaluating the SOFA score have demonstrated that this model may overpredict mortality for certain racial groups while underpredicting mortality for others, potentially due to the inclusion of variables that do not account for baseline physiological differences or chronic exposure to systemic stressors [<xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref17">17</xref>]. Similarly, investigations into the National Surgical Quality Improvement Program surgical risk calculator have found that while the model provides strong aggregate discrimination, it often underestimates complications and mortality for minority patients and those from lower socioeconomic backgrounds [<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref15">15</xref>,<xref ref-type="bibr" rid="ref16">16</xref>]. This study suggests that POSPOM exhibits a similar pattern where the model fails to calibrate for the higher baseline incidence of adverse outcomes in minoritized cohorts. This consistent trend across various clinical tools suggests that preoperative risk models may require the inclusion of social and structural variables to achieve true equity in predictions.</p></sec><sec id="s4-5"><title>Limitations in Subgroup Analyses</title><p>The absence of mortality events among several racial and ethnic subgroups highlights the small sample size challenge associated with these exploratory analyses [<xref ref-type="bibr" rid="ref18">18</xref>]. Similarly, the absence of events in the Hispanic subgroup limited the ability to assess POSPOM performance in this population. Larger sample sizes are needed to evaluate fairness and calibration across ethnic groups. In addition, the extremely low number of mortality events in the high-risk surgical subgroup limits the statistical power of the model&#x2019;s discrimination in this specific cohort; therefore, our high-risk analyses should be interpreted as exploratory and signal-generating rather than definitive. Furthermore, while the All of Us database provided a more diverse sample than many traditional datasets, the overall low event rate for 30-day mortality (0.1%) limits the precision of our estimates [<xref ref-type="bibr" rid="ref9">9</xref>]. These exploratory findings primarily underscore the need for larger, fully powered datasets to accurately evaluate subgroup performance.</p></sec><sec id="s4-6"><title>Clinical and Policy Implications</title><p>These results exemplify the potential danger of assuming that a clinically validated tool is neutral simply because it avoids subjective physician input. If POSPOM is used to guide surgical decision-making or resource allocation without recalibration for US populations, it may inadvertently exacerbate existing health disparities [<xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref19">19</xref>,<xref ref-type="bibr" rid="ref20">20</xref>]. For example, if a high-risk Black patient receives a risk score that discriminates well but overlooks a systematically higher baseline mortality, they may be given less aggressive preoperative optimization or postoperative surveillance than their true risk warrants. Ultimately, our findings suggest that the clinical utility of POSPOM in diverse US health care settings would be significantly enhanced by regional and demographic recalibration. Prioritized next steps should include using larger, multicenter US registries to reweight the tool&#x2019;s clinical variables and explicitly investigating whether the integration of specific social determinants of health can optimize baseline calibration across heterogeneous patient populations.</p></sec></sec></body><back><notes><sec><title>Generative AI Use</title><p>The authors used Cursor (an AI-powered editor) to help draft, debug, and refactor Python code for data processing and statistical analysis. All queries, analytic decisions, and outputs were reviewed and validated by the authors, who retain full responsibility for the manuscript.</p></sec><sec><title>Funding</title><p>No funding was received for this study.</p></sec><sec><title>Data Availability</title><p>The analytical code used for data processing and statistical analysis is not publicly available.</p><p>The data used in this study are available to registered, approved researchers through the National Institutes of Health All of Us Research Program&#x2019;s cloud-based platform. Detailed information on how to apply for data access can be found on the All of Us Research Program website [<xref ref-type="bibr" rid="ref21">21</xref>].</p></sec></notes><fn-group><fn fn-type="con"><p>Conceptualization: JH (lead), HW (equal)</p><p>Formal analysis: HW (lead)</p><p>Methodology: HW, JH, CP</p><p>Project administration: JH (lead), HW (equal)</p><p>Supervision: SA</p><p>Visualization: HW, CP</p><p>Writing&#x2014;original draft: JH (lead), CP (supporting), VB (supporting)</p><p>Writing&#x2014;review and editing: JH, HW, CP, VB, SA</p></fn><fn fn-type="conflict"><p>None declared.</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term id="abb1">AUC</term><def><p>area under the receiver operating characteristic curve</p></def></def-item><def-item><term id="abb2">EHR</term><def><p>electronic health record</p></def></def-item><def-item><term id="abb3">IRB</term><def><p>institutional review board</p></def></def-item><def-item><term id="abb4">NIH</term><def><p>National Institutes of Health</p></def></def-item><def-item><term id="abb5">OMOP</term><def><p>Observational Medical Outcomes Partnership</p></def></def-item><def-item><term id="abb6">OR</term><def><p>odds ratio</p></def></def-item><def-item><term id="abb7">POSPOM</term><def><p>Preoperative Score to Predict Postoperative Mortality</p></def></def-item><def-item><term id="abb8">SOFA</term><def><p>Sequential Organ Failure Assessment</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><label>1</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Le Manach</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Collins</surname><given-names>G</given-names> </name><name name-style="western"><surname>Rodseth</surname><given-names>R</given-names> </name><etal/></person-group><article-title>Preoperative Score to Predict Postoperative Mortality (POSPOM): derivation and validation</article-title><source>Anesthesiology</source><year>2016</year><month>03</month><volume>124</volume><issue>3</issue><fpage>570</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1097/ALN.0000000000000972</pub-id><pub-id pub-id-type="medline">26655494</pub-id></nlm-citation></ref><ref id="ref2"><label>2</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>T</given-names> </name><name name-style="western"><surname>Li</surname><given-names>X</given-names> </name><name name-style="western"><surname>Nylander</surname><given-names>W</given-names> </name><name name-style="western"><surname>Gunnar</surname><given-names>W</given-names> </name></person-group><article-title>Thirty-day postoperative mortality risk estimates and 1-year survival in Veterans Health Administration surgery patients</article-title><source>JAMA Surg</source><year>2016</year><month>05</month><day>1</day><volume>151</volume><issue>5</issue><fpage>417</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1001/jamasurg.2015.4882</pub-id><pub-id pub-id-type="medline">26747331</pub-id></nlm-citation></ref><ref id="ref3"><label>3</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaiser</surname><given-names>HA</given-names> </name><name name-style="western"><surname>Saied</surname><given-names>NN</given-names> </name><name name-style="western"><surname>Kokoefer</surname><given-names>AS</given-names> </name><name name-style="western"><surname>Saffour</surname><given-names>L</given-names> </name><name name-style="western"><surname>Zoller</surname><given-names>JK</given-names> </name><name name-style="western"><surname>Helwani</surname><given-names>MA</given-names> </name></person-group><article-title>Incidence and prediction of intraoperative and postoperative cardiac arrest requiring cardiopulmonary resuscitation and 30-day mortality in non-cardiac surgical patients</article-title><source>PLoS One</source><year>2020</year><month>01</month><day>22</day><volume>15</volume><issue>1</issue><fpage>e0225939</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0225939</pub-id><pub-id pub-id-type="medline">31967987</pub-id></nlm-citation></ref><ref id="ref4"><label>4</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Layer</surname><given-names>YC</given-names> </name><name name-style="western"><surname>Menzenbach</surname><given-names>J</given-names> </name><name name-style="western"><surname>Layer</surname><given-names>YL</given-names> </name><etal/></person-group><article-title>Validation of the Preoperative Score to Predict Postoperative Mortality (POSPOM) in Germany</article-title><source>PLoS One</source><year>2021</year><month>01</month><day>27</day><volume>16</volume><issue>1</issue><fpage>e0245841</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0245841</pub-id><pub-id pub-id-type="medline">33503043</pub-id></nlm-citation></ref><ref id="ref5"><label>5</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vigna</surname><given-names>C</given-names> </name><name name-style="western"><surname>Ore</surname><given-names>AS</given-names> </name><name name-style="western"><surname>Fabrizio</surname><given-names>A</given-names> </name><name name-style="western"><surname>Messaris</surname><given-names>E</given-names> </name></person-group><article-title>Evaluation of racial/ethnic disparities in surgical outcomes after rectal cancer resection: an ACS-NSQIP analysis</article-title><source>Surg Pract Sci</source><year>2024</year><month>04</month><day>17</day><volume>17</volume><fpage>100248</fpage><pub-id pub-id-type="doi">10.1016/j.sipas.2024.100248</pub-id><pub-id pub-id-type="medline">39845641</pub-id></nlm-citation></ref><ref id="ref6"><label>6</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Obermeyer</surname><given-names>Z</given-names> </name><name name-style="western"><surname>Powers</surname><given-names>B</given-names> </name><name name-style="western"><surname>Vogeli</surname><given-names>C</given-names> </name><name name-style="western"><surname>Mullainathan</surname><given-names>S</given-names> </name></person-group><article-title>Dissecting racial bias in an algorithm used to manage the health of populations</article-title><source>Science</source><year>2019</year><month>10</month><day>25</day><volume>366</volume><issue>6464</issue><fpage>447</fpage><lpage>453</lpage><pub-id pub-id-type="doi">10.1126/science.aax2342</pub-id><pub-id pub-id-type="medline">31649194</pub-id></nlm-citation></ref><ref id="ref7"><label>7</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brindle</surname><given-names>P</given-names> </name><name name-style="western"><surname>May</surname><given-names>M</given-names> </name><name name-style="western"><surname>Gill</surname><given-names>P</given-names> </name><etal/></person-group><article-title>Primary prevention of cardiovascular disease: a web-based risk score for seven British Black and minority ethnic groups</article-title><source>Heart</source><year>2006</year><month>11</month><volume>92</volume><issue>11</issue><fpage>1595</fpage><lpage>1602</lpage><pub-id pub-id-type="doi">10.1136/hrt.2006.092346</pub-id><pub-id pub-id-type="medline">16762981</pub-id></nlm-citation></ref><ref id="ref8"><label>8</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ashana</surname><given-names>DC</given-names> </name><name name-style="western"><surname>Anesi</surname><given-names>GL</given-names> </name><name name-style="western"><surname>Liu</surname><given-names>VX</given-names> </name><etal/></person-group><article-title>Equitably allocating resources during crises: racial differences in mortality prediction models</article-title><source>Am J Respir Crit Care Med</source><year>2021</year><month>03</month><day>30</day><volume>204</volume><issue>2</issue><fpage>178</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1164/rccm.202012-4383OC</pub-id><pub-id pub-id-type="medline">33751910</pub-id></nlm-citation></ref><ref id="ref9"><label>9</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><collab>All of Us Research Program Investigators</collab><name name-style="western"><surname>Denny</surname><given-names>JC</given-names> </name><name name-style="western"><surname>Rutter</surname><given-names>JL</given-names> </name><etal/></person-group><article-title>The &#x201C;All of Us&#x201D; Research Program</article-title><source>N Engl J Med</source><year>2019</year><month>08</month><day>15</day><volume>381</volume><issue>7</issue><fpage>668</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.1056/NEJMsr1809937</pub-id><pub-id pub-id-type="medline">31412182</pub-id></nlm-citation></ref><ref id="ref10"><label>10</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Overhage</surname><given-names>JM</given-names> </name><name name-style="western"><surname>Ryan</surname><given-names>PB</given-names> </name><name name-style="western"><surname>Reich</surname><given-names>CG</given-names> </name><name name-style="western"><surname>Hartzema</surname><given-names>AG</given-names> </name><name name-style="western"><surname>Stang</surname><given-names>PE</given-names> </name></person-group><article-title>Validation of a common data model for active safety surveillance research</article-title><source>J Am Med Inform Assoc</source><year>2012</year><volume>19</volume><issue>1</issue><fpage>54</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1136/amiajnl-2011-000376</pub-id><pub-id pub-id-type="medline">22037893</pub-id></nlm-citation></ref><ref id="ref11"><label>11</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Hond</surname><given-names>AA</given-names> </name><name name-style="western"><surname>Steyerberg</surname><given-names>EW</given-names> </name><name name-style="western"><surname>van Calster</surname><given-names>B</given-names> </name></person-group><article-title>Interpreting area under the receiver operating characteristic curve</article-title><source>Lancet Digit Health</source><year>2022</year><month>12</month><volume>4</volume><issue>12</issue><fpage>e853</fpage><lpage>e855</lpage><pub-id pub-id-type="doi">10.1016/S2589-7500(22)00188-1</pub-id><pub-id pub-id-type="medline">36270955</pub-id></nlm-citation></ref><ref id="ref12"><label>12</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reames</surname><given-names>BN</given-names> </name><name name-style="western"><surname>Birkmeyer</surname><given-names>NJ</given-names> </name><name name-style="western"><surname>Dimick</surname><given-names>JB</given-names> </name><name name-style="western"><surname>Ghaferi</surname><given-names>AA</given-names> </name></person-group><article-title>Socioeconomic disparities in mortality after cancer surgery: failure to rescue</article-title><source>JAMA Surg</source><year>2014</year><month>05</month><volume>149</volume><issue>5</issue><fpage>475</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1001/jamasurg.2013.5076</pub-id><pub-id pub-id-type="medline">24623106</pub-id></nlm-citation></ref><ref id="ref13"><label>13</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wakeam</surname><given-names>E</given-names> </name><name name-style="western"><surname>Hevelone</surname><given-names>ND</given-names> </name><name name-style="western"><surname>Maine</surname><given-names>R</given-names> </name><etal/></person-group><article-title>Failure to rescue in safety-net hospitals: availability of hospital resources and differences in performance</article-title><source>JAMA Surg</source><year>2014</year><month>03</month><volume>149</volume><issue>3</issue><fpage>229</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1001/jamasurg.2013.3566</pub-id><pub-id pub-id-type="medline">24430015</pub-id></nlm-citation></ref><ref id="ref14"><label>14</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tolchin</surname><given-names>B</given-names> </name><name name-style="western"><surname>Oladele</surname><given-names>C</given-names> </name><name name-style="western"><surname>Galusha</surname><given-names>D</given-names> </name><etal/></person-group><article-title>Racial disparities in the SOFA score among patients hospitalized with COVID-19</article-title><source>PLoS One</source><year>2021</year><month>09</month><day>17</day><volume>16</volume><issue>9</issue><fpage>e0257608</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0257608</pub-id><pub-id pub-id-type="medline">34535009</pub-id></nlm-citation></ref><ref id="ref15"><label>15</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matar</surname><given-names>DY</given-names> </name><name name-style="western"><surname>Knoedler</surname><given-names>S</given-names> </name><name name-style="western"><surname>Matar</surname><given-names>AY</given-names> </name><etal/></person-group><article-title>Surgical outcomes and sociodemographic disparities across all races: an ACS-NSQIP and NHIS multi-institutional analysis of over 7.5 million patients</article-title><source>Ann Surg Open</source><year>2024</year><month>07</month><day>16</day><volume>5</volume><issue>3</issue><fpage>e467</fpage><pub-id pub-id-type="doi">10.1097/AS9.0000000000000467</pub-id><pub-id pub-id-type="medline">39310358</pub-id></nlm-citation></ref><ref id="ref16"><label>16</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Betancourt-Garcia</surname><given-names>MM</given-names> </name><name name-style="western"><surname>Vatcheva</surname><given-names>K</given-names> </name><name name-style="western"><surname>Gupta</surname><given-names>PK</given-names> </name><etal/></person-group><article-title>The effect of Hispanic ethnicity on surgical outcomes: an analysis of the NSQIP database</article-title><source>Am J Surg</source><year>2019</year><month>04</month><volume>217</volume><issue>4</issue><fpage>618</fpage><lpage>633</lpage><pub-id pub-id-type="doi">10.1016/j.amjsurg.2018.10.004</pub-id><pub-id pub-id-type="medline">30466953</pub-id></nlm-citation></ref><ref id="ref17"><label>17</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sarkar</surname><given-names>R</given-names> </name><name name-style="western"><surname>Martin</surname><given-names>C</given-names> </name><name name-style="western"><surname>Mattie</surname><given-names>H</given-names> </name><name name-style="western"><surname>Gichoya</surname><given-names>JW</given-names> </name><name name-style="western"><surname>Stone</surname><given-names>DJ</given-names> </name><name name-style="western"><surname>Celi</surname><given-names>LA</given-names> </name></person-group><article-title>Performance of intensive care unit severity scoring systems across different ethnicities in the USA: a retrospective observational study</article-title><source>Lancet Digit Health</source><year>2021</year><month>04</month><volume>3</volume><issue>4</issue><fpage>e241</fpage><lpage>e249</lpage><pub-id pub-id-type="doi">10.1016/S2589-7500(21)00022-4</pub-id><pub-id pub-id-type="medline">33766288</pub-id></nlm-citation></ref><ref id="ref18"><label>18</label><nlm-citation citation-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Walker</surname><given-names>R</given-names> </name><name name-style="western"><surname>Behman</surname><given-names>R</given-names> </name><name name-style="western"><surname>Bubis</surname><given-names>L</given-names> </name><name name-style="western"><surname>Karanicolas</surname><given-names>P</given-names> </name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Thoma</surname><given-names>A</given-names> </name><name name-style="western"><surname>Sprague</surname><given-names>S</given-names> </name><name name-style="western"><surname>Voineskos</surname><given-names>SH</given-names> </name><name name-style="western"><surname>Serrano</surname><given-names>PE</given-names> </name><name name-style="western"><surname>Goldsmith</surname><given-names>CH</given-names> </name></person-group><article-title>Prospective and retrospective cohort studies</article-title><source>Evidence-Based Surgery: A Guide to Understanding and Interpreting the Surgical Literature</source><year>2025</year><publisher-name>Springer</publisher-name><fpage>191</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1007/978-3-031-87083-5_17</pub-id></nlm-citation></ref><ref id="ref19"><label>19</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chin</surname><given-names>MH</given-names> </name><name name-style="western"><surname>Afsar-Manesh</surname><given-names>N</given-names> </name><name name-style="western"><surname>Bierman</surname><given-names>AS</given-names> </name><etal/></person-group><article-title>Guiding principles to address the impact of algorithm bias on racial and ethnic disparities in health and health care</article-title><source>JAMA Netw Open</source><year>2023</year><month>12</month><day>1</day><volume>6</volume><issue>12</issue><fpage>e2345050</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2023.45050</pub-id><pub-id pub-id-type="medline">38100101</pub-id></nlm-citation></ref><ref id="ref20"><label>20</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vyas</surname><given-names>DA</given-names> </name><name name-style="western"><surname>Eisenstein</surname><given-names>LG</given-names> </name><name name-style="western"><surname>Jones</surname><given-names>DS</given-names> </name></person-group><article-title>Hidden in plain sight - reconsidering the use of race correction in clinical algorithms</article-title><source>N Engl J Med</source><year>2020</year><month>08</month><day>27</day><volume>383</volume><issue>9</issue><fpage>874</fpage><lpage>882</lpage><pub-id pub-id-type="doi">10.1056/NEJMms2004740</pub-id><pub-id pub-id-type="medline">32853499</pub-id></nlm-citation></ref><ref id="ref21"><label>21</label><nlm-citation citation-type="web"><source>All of Us Research Program</source><access-date>2026-11-13</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.nih.gov/allofus">https://www.nih.gov/allofus</ext-link></comment></nlm-citation></ref></ref-list></back></article>